US2017354662A1PendingUtilityA1

Methods and compositions for treating migraines using noribogaine

51
Assignee: DEMERX INCPriority: Jul 14, 2014Filed: Jan 23, 2017Published: Dec 14, 2017
Est. expiryJul 14, 2034(~8 yrs left)· nominal 20-yr term from priority
Inventors:Holger Weis
A61K 31/55A61K 45/06A61K 31/485A61K 31/573
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides methods and compositions for treating or preventing migraine headache and/or symptoms thereof in a subject. The method comprises administering to the subject in need thereof a therapeutically effective amount of noribogaine, noribogaine derivative, or a pharmaceutically acceptable salt thereof.

Claims

exact text as granted — not AI-modified
1 . A method for treating migraine headache and/or symptoms thereof in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of noribogaine, noribogaine derivative, or a pharmaceutically acceptable salt thereof. 
     
     
         2 - 14 . (canceled) 
     
     
         15 . A pharmaceutical composition comprising a therapeutically effective amount of noribogaine, noribogaine derivative, or pharmaceutically acceptable salt thereof, at least one agent for treating or preventing migraine headache, and a pharmaceutically acceptable excipient. 
     
     
         16 - 26 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.